$1.1M Order Extends Partnership and Positions Adept as Leader in Emerging Robotics Market
LIVERMORE, Calif. --Dec. 7, 2005--Adept Technology, Inc.
(Nasdaq:ADEP), the leading provider of intelligent vision-guided robotics and global robotics services, announced today that they have been chosen by Becton, Dickinson and Company, as their robotics automation supplier for the BD ProbeTec(TM) molecular diagnostics system, a ground-breaking platform, for in vitro diagnostic applications.The $1.1M order for Adept Cobra(TM) s600 SCARA robots are used in pipette-transfer applications in the BD Viper(TM) System, recently cleared by the FDA. The BD Viper System is an intelligent, high-volume, fully automated laboratory testing processor.
The unique design and performance of the Adept Cobra is critical for accurate in vitro testing due to the highly controlled and regulated nature of the laboratory environment.The Adept Cobra ensures the highest standard of reliability and performance in the process of pipette transfers. In comparison to manual pipetting in a laboratory environment, the Adept Cobra reduces repetitive motions and errors, thereby eliminating fatigue and distraction, which can critically affect important diagnostic results. Adept Cobras enable the limited number of technologists to work at a greater level of efficiency by increasing their productivity and minimizing their risk of injury."
We are excited to be teamed with Becton Dickinson in the field of laboratory automation," said Robert Bucher, Chairman and CEO of Adept Technology, Inc. "This order strengthens a strategic relationship, and leverages Becton Dickinson's leadership position in medical diagnostics and laboratory equipment."
BD Diagnostics
BD Diagnostics is a leading provider of products for the safe collection and transport of diagnostic specimens, and of instrumentation for quick, accurate analysis for a broad range of microbiology and infectious disease testing. These products provide the diagnostic industry with high quality, efficient arrays for the pre-analytical activity of blood collection, and for routine microbiology and infectious disease testing. Adept Technology, Inc. Adept Technology, Inc. designs, manufactures and markets robotic systems, motion control and machine vision technology for global markets including automotive, consumer electronics, consumer goods, food, industrial tooling, medical devices, and pharmaceutical.
Adept robots, controllers, and software are used for small parts assembly, material handling and packaging. Adept intelligent automation product lines include industrial robots, configurable linear modules, machine controllers for robot mechanisms and other flexible automation equipment, machine vision, and systems and applications software. Founded in 1983, Adept Technology is the largest U.S. -based manufacturer of industrial robots.
More information is available at www.adept.com .This press release contains certain forward-looking statements including statements regarding future operational performance that involve a number of risks and uncertainties.
The company's actual results could differ materially from those expressed in any of the above forward-looking statements for a variety of reasons, including but not limited to, future economic, competitive and market conditions including those in Europe and Asia and those related to the company's strategic markets; the company's dependence on the continued growth of the intelligent automation market; the company's highly competitive industry; rapid technological change within the intelligent automation industry; the lengthy sales cycles for the company's products; the company's significant fixed costs which are not easily reduced; the risks associated with sole or single sources of supply and lengthy procurement lead times; dependence upon the company's suppliers; the risks associated with product defects; the potential delays associated with the development and introduction of new products or software releases; or decreased acceptance of the company's new or current products in the marketplace.For a discussion of risk factors relating to Adept's business, see Adept's annual report on Form 10-K for the fiscal year ended June 30, 2005 and the quarterly report on Form 10-Q for the quarter ended October 2, 2005, including the discussion in Management's Discussion and Analysis of Financial Condition and Results of Operations and Factors Affecting Future Operating Results contained therein.
